Veronique R De Jager

5PUBLICATIONS
39CO-AUTHORS
MycologyMedical bacteriologyMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 08, 2026
Modeling Treatment Response in Tuberculosis Early Bactericidal Activity Trials.

|Jun 02, 2025
A Phase 2a Study of the Early Bactericidal Activity of Rifampicin in Combination With Meropenem Plus Amoxicillin/Clavulanate Among Adults With Rifampicin-Resistant Pulmonary Tuberculosis.

Veronique de Jager, Laurynas Mockeliunas, Huifang You

|Sep 26, 2023
Cough as Noninvasive Biomarker for Monitoring Tuberculosis Treatment: A Proof-of-Concept Study.

Saskia Janssen, Caryn M Upton, Veronique R De Jager

|Mar 08, 2022
Early Bactericidal Activity of Meropenem plus Clavulanate (with or without Rifampin) for Tuberculosis: The COMRADE Randomized, Phase 2A Clinical Trial.

Veronique De Jager, Nikhil Gupte, Silvia Nunes

|Feb 04, 2021
Fourteen-day PET/CT imaging to monitor drug combination activity in treated individuals with tuberculosis.

Yingda L Xie, Veronique R de Jager, Ray Y Chen

Pageof 1

Frequent Collaborators

3 joint publications

Andreas H Diacon

2 joint publications

Elin M Svensson

2 joint publications

Ulrika S H Simonsson

2 joint publications

Kelly E Dooley